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Abstract 
 To find-out the leading causes and the possible environmental contributors for End 
Stage Renal Disease (ESRD) in Al-Madinah region, KSA.. 156 patients suffering from ESRD 
and 160 apparently healthy subjects of comparable age and sex were included. None of the 
participants was occupationally exposed to lead, cadmium and/or mercury. None affection of 
the control subjects with renal diseases was confirmed. Patients with undefined leading 
causes for ESRD (44) and an equal number of the control subjects were subjected to 
determine their blood levels of lead, cadmium and mercury. The study revealed that the main 
leading causes of ESRD in Al-Madinah region were hypertension, obstructive uropathy and 
diabetes mellitus. Environmental pollutants of lead (Pb) and cadmium (Cd) contributed to 
ESRD in Al-Madinah region particularly in urban areas. Mercury (Hg) was not a pollutant in 
Al-Madinah region. The study recommended early diagnosis and proper control of 
hypertension, obstructive uropathy and diabetes mellitus. It also recommended regular 
environmental monitoring for (Pb) and cadmium (Cd) levels and finds the sources of their 
elevations and efforts should be raised up to eliminate them.    
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Aim 
 The present study was conducted to find–out the most leading causes of ESRD and 
the role of nephrotoxic heavy metals in patients when no leading causes could be identified in 
Al-Madinah region. 
 
Methods 
 A case control study was done in a private hospital and a charity kidney association 
that has a kidney dialysis center. 156 ESRD patients and 160 healthy subjects of comparable 
age and sex were included. A serum sample was taken from each of the patients and control 
subjects and was tested for lead, cadmium and mercury by using atomic absorption 
spectrophelometery. Urea and creatinin serum levels were also estimated using standard 
laboratory techniques. 
 Data were analyzed using SPSS-14, utilizing Students t test and the Chi square test as 
an appropriate. The adapted level of significance was 0.05. Correlations coefficient (r) was 
used to assess the presence of linear correlations. 
 
Introduction 
         There has been a marked rise in the prevalence and incidence of end stage chronic 
kidney disease (CKD) in Saudi Arabia over the last three decades(1). 
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         The first dialysis session in Saudi Arabia took place in 1971 and the first renal 
transplant in 1979. By the end of 2008, there were 10,203 patients on hemodialysis, 966 on 
peritoneal dialysis, and 7836 with functioning kidney grafts(2). 
         The over-all prevalence of CRF was 5.7 %(3). This rise exceeds those reported from 
many countries. The enormous and rapid changes in lifestyle, high population growth, fast 
increase in life expectancy, and massive urbanization that has occurred over the last 3 
decades combined to make the current CKD status different to what it was(1). 
         The major factors that influence the CKD status are the very high rate of diabetic 
nephropathy and shift in age demographics(4). There are no available data about the possible 
environmental factors that may contribute to this rising prevalence in the general population 
of the kingdom of Saudi Arabia. Worldwide, one third of the patients with chronic renal 
failure had no obvious predisposing disease(4). One of the silent leading causes of chronic 
renal failure is the chronic interstitial nephritis secondary to various nephrotoxins(5). 
         Heavy metals particularly; lead (Pb), cadmium (Cd) and mercury (Hg) are the most 
nephrotoxic environmental pollutants(6). 
         Chronic exposure to cadmium, (an industrial and environmental pollutant that is found 
in Tobacco smoke , fresh and canned fish and  processed vegetable products), can cause both 
renal proximal tubular damage and decline in glomerular filtration rate (GFR) in humans; this 
has been confirmed in experimental models(7,8 ,9). 
         Cadmium nephropathy is characterized by low molecular weight (LMW) proteinuria 
due to diminished intrarenal uptake and catabolism of filtered proteins. In cadmium 
nephropathy, proximal tubular dysfunction persists until renal failure supervenes(10). 
         Although cadmium nephropathy has been observed in workers exposed to high levels of 
Cd, recent data suggest that relatively low levels of exposure in people living in polluted 
industrial areas increase the risk of tubular dysfunction(7). 
            Lead-induced nephropathy is well recognized in persons with a high level of exposure 
to lead(11-14). 
 The usual sources of lead are lead additives in motor fuels, lead water pipes, lead 
containing paints, smoking besides canned food and drinks(15). 
 Several epidemiologic studies have demonstrated a positive association between 
blood lead levels and the rate of the usual decrease in renal function that occurs with age in 
the general population(16-18). 
 
Subjects and methods 
Patients 
 The present study comprised 156 ESRD patients who were recruited from 
hemodialysis centers of Madinah National Hospital (MNH), and Al-Azhari Kidney Charity 
Centre during the period of the study (three months). Only patients on maintenance 
hemodialysis who were aged 16 years or more and who underwent hemodialysis for 6 months 
were enrolled in the study. Patients with any obvious chronic autoimmune diseases and those 
who had been hospitalized or had undergone surgery within the last 3 months before starting 
of the study were excluded. In addition, a questionnaire was arranged to survey patients who 
had a history of occupational exposure to lead or previous lead intoxication or those living in 
lead-contaminated areas also were excluded. Most of the patients has been undergone 4 hours 
hemodialysis, 3 times per week. Hemodialysis for these patients was carried out using single-
use, hollow-fiber dialyzers equipped with modified cellulose, polyamide, or polysulfone 
membranes. Medical records of the ESRD patients were revised. 
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Controls 
 160 age and sex matched group of controls were randomly selected from those 
healthy subjects working in the same hemodialysis centers or visitors to MNH accompanying 
a relative during his / her visit to different patient clinics at MNH. Controls that had chronic 
illnesses or known to have an occupation that exposes them to environmental toxins were 
excluded by using the same questionnaires applied for the patient group. A random urine 
sample from each control subject was tested for albuminurea using Albustix to exclude renal 
disease subjects.  
 All subjects included in the study were interviewed for thorough history taking and 
physical examination.   
 
Laboratory and Biochemical Procedures 
 Controlled group was subjected to urine Albustix to test for albuminuria in order to 
exclude renal disease.  
 Blood samples from each of the patients were collected in a glass tube from the 
arterial end of the vascular access immediately after initiating a 2-day hemodialysis at mid-
week. From controls, blood samples were extracted from peripheral veins. All samples were 
centrifuged, and stored at −80° C for further analysis and measurement of blood lead, 
cadmium, mercury levels and biochemical data. Both groups were tested for blood 
hemoglobin, urea, creatinine and albumin.  Serum high sensitivity C-reactive protein 
concentrations were measured by immunonephelometry. 
 The clearance of urea through dialysis was expressed as Kt/V, using the Daugirdas20 
method. Abnormal high-sensitivity C-reactive protein level was defined as>3.0 mg/L, which 
corresponded to the level in patients on maintenance hemodialysis with an increased 
cardiovascular risk. Abnormal serum albumin level was defined as<3.5 g/dL,. 
 Blood lead, cadmium and mercury levels were measured using an electro-thermal 
atomic-absorption spectrometer (Spectra A-200Z; Varian, Lexington, Mass) (19). Because 
most of lead exists in red blood cells, blood lead level is corrected by Zeeman Background 
Correction and L'vov platform hemoglobin (corrected blood lead level). In men, corrected 
blood lead level = blood lead level×14.0 /hemoglobin levels, in women, corrected blood lead 
level=blood lead level×12 /hemoglobin levels.  
The mean blood   levels were stratified into 2 equal groups: low blood lead levels and high 
blood lead level according to each matter range values. 
 
Statistical analysis 
 Data were analyzed statistically by using Student's "t" test and the Chi square (𝜒2) 
test as appropriate. The adopted level of significance was 0.05. Correlation coefficient (r) was 
used to assess the presence of linear correlation between blood lead, cadmium and mercury 
levels and each of blood urea and serum creatinine levels(20). 
 
Results 
 Table (1) displays characteristics of the studied groups. It shows that no significant 
difference did occur between patients and control subjects regarding the average age (t = 
1.495), sex distribution (𝛘2 = 0.023) and residence (𝛘2 = 0.455).  
 Table (2) shows leading causes for chronic renal failure among patients and the 
control subjects. It shows that hypertension, obstructive uropathy and diabetes mellitus were 
associated with chronic renal failure in significant higher frequency than those in the control 
subjects (𝛘2 = 24.426, 21.864 and 17.661 respectively) . Polycystic kidney did not occur 
among the control subjects while 13 chronic renal failure patients (8.4%) suffered from that 
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disease. Undefined leading causes for chronic renal failure were observed in 28.2% of the 
patients. 
 Table (3) shows residence and smoking habit among chronic renal failure patients 
with undefined leading causes and the control subjects. It shows that more than two thirds of 
the patients (70.45%) were living in urban areas compared to 36.36% of the control subjects. 
The difference was statistically significant (𝛘2 = 10.276). The table sows also that smoking 
was reported by 50% of the chronic renal failure patients. Compared with 47.73% of the 
control subjects, the difference was insignificant (𝛘2 = 0.045). 
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 Table (4) displays average of blood levels of lead, cadmium and mercury among 
chronic renal failure patients and the control subjects according to residence. It reveals that 
whatever the residence, the averages of the blood levels of lead and cadmium were 
significantly higher among chronic renal failure patients compared to the control subjects. 
Averages of blood levels of mercury in chronic renal failure patients did not differ from those 
of the control subjects whether living in urban or rural areas (t= 0.491 and 0.00 respectively). 
Averages of blood lead and cadmium levels were significantly among residence in urban 
areas compared to those in rural areas whether they suffer from chronic renal failure or not. 
 Table (5) shows correlations between blood levels of the heavy metals (lead, 
cadmium and mercury) and each of serum urea and creatinine. Blood mercury level did not 
correlate with neither serum urea nor serum creatinine (r = 0.021 and 0.049 respectively).      
 
Discussion 
 The finding that the undefined leading causes for chronic renal failure was 
encountered in more than a quarter of patients (28.2%), agrees with many authors (21,22) but 
disagrees with others(23-25). Discrepancies in the detectability rates of leading causes of ESRD 
in different areas or countries are dependent on the comprehensiveness of the diagnostic 
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approach and facilities as well as awareness with the relevant local environmental hazards(26). 
According to Nordfors et al. and Choi et al., hypertension and diabetes mellitus are the main 
leading causes for ESRD in USA(27,28). These data were confirmed by the annual United 
States Renal Data 2011(29). The present work added obstructive uropathy as a leading cause 
of equal frequency or even more with diabetes mellitus. This high frequency of obstructive 
uropathy among patients with ESRD was contrary with the finding of Norris and Agodoa 
(2005) as well as Warren et al. (2004)(30,31). This might be explained on the basis of the high 
prevalence of multiple types and sizes of renal stones associated with different pictures of 
renal strictures in the studied area. a matter that was supported by the observation that more 
than two thirds of the ESRD (69.23%) were living in rural areas. According to El Minshawy , 
obstructive uropathy related to schistosomiasis is more powerful renal failure inducer 
compared to other reasons of obstructive uropathy(22). This might be attributed to an 
associated immune complex nephritis exerting a synergistic effect towards chronic renal 
failure(32).  
             The estimated high frequencies of ESRD with undefined leading causes has triggered 
thinking of chronic interstitial nephritis which might be incidious, symptomless and often 
presenting as secondary hypertension or unexplained chronic renal failure(5). Thijssen et al. 
postulated that environmental pollutants might be the underlying cause for such chronic 
interstitial nephritis(8). In this work; whether in the urban or the rural residence, the averages 
of blood lead levels among ESRD patients were not only significantly higher than those of 
the control subjects, but also far beyond the normal limit (15µg/dl)(24). According to Weeden 
(1992), blood lead level over 15 µg/dl is associated with lead-induced organ damage(12). The 
significant positive correlation between blood lead level and each of serum urea and 
creatinine pointed to amenability of renal tissue to lead-induced damage. This was in line 
with Kim et al. who reported that the increased body lead burden contributes to a significant 
portion of chronic renal failure(18).  
              The finding that urban inhabitants had significant higher averages of blood lead 
levels compared to rural ones should indicate more environmental pollution with lead in 
urban areas as none of the studied groups was occupationally exposed to lead. Moreover, 
frequencies of smokers among urban and rural inhabitants in this study were nearly equal. 
According to Nuyts et al. and Staessen, leaded-gasoline used for motor running is the main 
source for environmental pollution in urban areas due to traffic overcrowding. Rural areas are 
less exposed due to fewer number of running cars(14,16).  
           In the present study, the significant higher averages of blood cadmium levels among 
chronic renal failure patients compared to the control subjects, agree with Järup et al. and 
Ferraro et al.(7,10). This in addition to the significant positive correlation between blood 
cadmium level and each of serum urea and creatinine reflect the role of cadmium exposure in 
the occurrence of chronic renal failure. Also, the observed significant higher averages of 
blood cadmium levels among urban inhabitants compared to rural ones might reflect more 
environmental pollution in urban areas. This was in line with Francis et al.(9) Hallan and Orth 
incriminated smoking while Milman et al. incriminated the more consumption of tinned fish 
and vegetables(33,34). However the equal rates of smoking in urban and rural areas excluded 
smoking from being the main source of cadmium pollution in urban areas. 
              In this study, the averages of blood mercury levels among chronic renal failure 
patients and the control subjects were ˂ 1 µg/dl which is the cut-off level for toxicity as 
determined by WHO (1977)(35). The observed apparently higher mercury levels in chronic 
renal failure patients compared with control subjects might be explained on the basis that, 
kidneys in patients with chronic renal failure are not yet able to clear the accumulated body 
mercury from whatever source resulting in the slight higher blood mercury concentration(36). 
The slight elevation of blood mercury level is a result not a cause as confirmed by the lack of 
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correlation between blood mercury levels and each of the serum urea and creatinine (table 5). 
Therefore, mercury might not be an environmental pollutants in Al-Madinah region.            
 
Conclusion  
 The well defined leading causes for chronic renal failure in Madinah Region, KSA., 
were hypertension, diabetes mellitus and obstructive uropathy. Urban areas were significantly 
more affecting by environmental pollutions. We attribute pollution in urban areas to heavy 
traffic by all kinds of cars and preferred use of the majority of population to the caned and 
preserved food and drinks.     
 
Recommendations 
            The following might minimize the occurrence of chronic renal failure: 
1- The health care strategy should emphasize early case finding and proper control of 
hypertension, diabetes mellitus and obstructive uropathy. 
2- There should be regular environmental monitoring of heavy metals particularly lead 
and cadmium levels. 
3- Sources of detected pollutants should be periodically investigated and should be 
treated or eliminated. 
4- Industrial or service activities associated with environmental pollution with heavy 
metals should be away from the residential areas 
5- Lead-free gasoline should be made the only available engine fuel and its use should 
be generalized. 
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